Award
National Cancer Institute 5U01CA253540-05
Systems Approaches to Understanding Subpopulation Heterogeneity in Therapeutic Resistance
Recipient
University of Texas at Austin, Department of Internal Medicine/Medicine
Award Amount
$319,766.00
Ceiling
$319,766.00
Awarded
August 26, 2024
Identifier
5U01CA253540-05
NIH/NCI funded research to study therapeutic resistance in triple-negative breast cancer by tracking cell subpopulations and developing predictive models.
Description
Research project funded by NIH/NCI focusing on cancer heterogeneity and therapeutic resistance in triple-negative breast cancer. The project develops experiment-computational workflows to measure, track, and predict the behavior of heterogeneous triple-negative breast cancer cells.